Cargando…
Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes
The major histocompatibility complex class Ib protein, Qa-1(b), serves as a ligand for murine CD94/NKG2A natural killer (NK) cell inhibitory receptors. The Qa-1(b) peptide-binding site is predominantly occupied by a single nonameric peptide, Qa-1 determinant modifier (Qdm), derived from the leader s...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193274/ https://www.ncbi.nlm.nih.gov/pubmed/10974028 |
_version_ | 1782147432175370240 |
---|---|
author | Kraft, Jennifer R. Vance, Russell E. Pohl, Jan Martin, Amy M. Raulet, David H. Jensen, Peter E. |
author_facet | Kraft, Jennifer R. Vance, Russell E. Pohl, Jan Martin, Amy M. Raulet, David H. Jensen, Peter E. |
author_sort | Kraft, Jennifer R. |
collection | PubMed |
description | The major histocompatibility complex class Ib protein, Qa-1(b), serves as a ligand for murine CD94/NKG2A natural killer (NK) cell inhibitory receptors. The Qa-1(b) peptide-binding site is predominantly occupied by a single nonameric peptide, Qa-1 determinant modifier (Qdm), derived from the leader sequence of H-2D and L molecules. Five anchor residues were identified in this study by measuring the peptide-binding affinities of substituted Qdm peptides in experiments with purified recombinant Qa-1(b). A candidate peptide-binding motif was determined by sequence analysis of peptides eluted from Qa-1 that had been folded in the presence of random peptide libraries or pools of Qdm derivatives randomized at specific anchor positions. The results indicate that Qa-1(b) can bind a diverse repertoire of peptides but that Qdm has an optimal primary structure for binding Qa-1(b). Flow cytometry experiments with Qa-1(b) tetramers and NK target cell lysis assays demonstrated that CD94/NKG2A discriminates between Qa-1(b) complexes containing peptides with substitutions at nonanchor positions P4, P5, or P8. Our findings suggest that it may be difficult for viruses to generate decoy peptides that mimic Qdm and raise the possibility that competitive replacement of Qdm with other peptides may provide a novel mechanism for activation of NK cells. |
format | Text |
id | pubmed-2193274 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2000 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21932742008-04-16 Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes Kraft, Jennifer R. Vance, Russell E. Pohl, Jan Martin, Amy M. Raulet, David H. Jensen, Peter E. J Exp Med Original Article The major histocompatibility complex class Ib protein, Qa-1(b), serves as a ligand for murine CD94/NKG2A natural killer (NK) cell inhibitory receptors. The Qa-1(b) peptide-binding site is predominantly occupied by a single nonameric peptide, Qa-1 determinant modifier (Qdm), derived from the leader sequence of H-2D and L molecules. Five anchor residues were identified in this study by measuring the peptide-binding affinities of substituted Qdm peptides in experiments with purified recombinant Qa-1(b). A candidate peptide-binding motif was determined by sequence analysis of peptides eluted from Qa-1 that had been folded in the presence of random peptide libraries or pools of Qdm derivatives randomized at specific anchor positions. The results indicate that Qa-1(b) can bind a diverse repertoire of peptides but that Qdm has an optimal primary structure for binding Qa-1(b). Flow cytometry experiments with Qa-1(b) tetramers and NK target cell lysis assays demonstrated that CD94/NKG2A discriminates between Qa-1(b) complexes containing peptides with substitutions at nonanchor positions P4, P5, or P8. Our findings suggest that it may be difficult for viruses to generate decoy peptides that mimic Qdm and raise the possibility that competitive replacement of Qdm with other peptides may provide a novel mechanism for activation of NK cells. The Rockefeller University Press 2000-09-05 /pmc/articles/PMC2193274/ /pubmed/10974028 Text en © 2000 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Original Article Kraft, Jennifer R. Vance, Russell E. Pohl, Jan Martin, Amy M. Raulet, David H. Jensen, Peter E. Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes |
title | Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes |
title_full | Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes |
title_fullStr | Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes |
title_full_unstemmed | Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes |
title_short | Analysis of Qa-1(b)Peptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes |
title_sort | analysis of qa-1(b)peptide binding specificity and the capacity of cd94/nkg2a to discriminate between qa-1–peptide complexes |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193274/ https://www.ncbi.nlm.nih.gov/pubmed/10974028 |
work_keys_str_mv | AT kraftjenniferr analysisofqa1bpeptidebindingspecificityandthecapacityofcd94nkg2atodiscriminatebetweenqa1peptidecomplexes AT vancerusselle analysisofqa1bpeptidebindingspecificityandthecapacityofcd94nkg2atodiscriminatebetweenqa1peptidecomplexes AT pohljan analysisofqa1bpeptidebindingspecificityandthecapacityofcd94nkg2atodiscriminatebetweenqa1peptidecomplexes AT martinamym analysisofqa1bpeptidebindingspecificityandthecapacityofcd94nkg2atodiscriminatebetweenqa1peptidecomplexes AT rauletdavidh analysisofqa1bpeptidebindingspecificityandthecapacityofcd94nkg2atodiscriminatebetweenqa1peptidecomplexes AT jensenpetere analysisofqa1bpeptidebindingspecificityandthecapacityofcd94nkg2atodiscriminatebetweenqa1peptidecomplexes |